Masaru Konishi

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Medicine, Oncology, Chemotherapy +7

Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer

Tomoki Ebata, Satoshi Hirano, Masaru Konishi et al. · British journal of surgery · 2018 · 395 citations

Medicine, Oncology, Cancer Control +12

Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Yu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka et al. · Clinical Cancer Research · 2012 · 299 citations

Medicine, Immunology, Oncology +17

Glypican‐3 expression is correlated with poor prognosis in hepatocellular carcinoma

Hirofumi Shirakawa, Hitomi Suzuki, Manami Shimomura et al. · Cancer Science · 2009 · 276 citations · Full text

Medicine, Oncology, Pathology +17

Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study

Takeshi Takahara, Go Wakabayashi, Toru Beppu et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2015 · 263 citations · Full text

Medicine, Perioperative Medicine, Surgery +14